PONATINIB EVALUATION AND SAFETY IN REAL LIFE CHRONIC PHASE (CP) CML PATIENTS FAILING >= 2 TYROSINE KINASE INHIBITORS (TKI): UPDATE OF THE PEARL OBSERVATIONAL STUDY

Affiliation auteurs!!!! Error affiliation !!!!
TitrePONATINIB EVALUATION AND SAFETY IN REAL LIFE CHRONIC PHASE (CP) CML PATIENTS FAILING >= 2 TYROSINE KINASE INHIBITORS (TKI): UPDATE OF THE PEARL OBSERVATIONAL STUDY
Type de publicationJournal Article
Year of Publication2016
AuteursNicolini F.E, Heiblig M., Caillot D., Charbonnier A., Rousselot P., Coiteux V., Escoffre-Barbe M., Dubruille V., Huguet F., Guilhot F., Hermet E., Guerci-Bresler A., Ame S., Mouchel P., Roy L., Morisset S., Etienne G., Rea D.
JournalHAEMATOLOGICA
Volume101
Pagination456
Date PublishedJUN
Type of ArticleMeeting Abstract
ISSN0390-6078